RevMedx receives CE Mark for XSTAT® injectable hemostatic devices.

Friday, April 6, 2018 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

Revolutionary bleeding control technology will now be available in Europe and other International markets.

WILSONVILLE, Ore., April 6, 2018 /PRNewswire-iReach/ -- RevMedx, Inc., a leader in innovative devices that control severe

bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XSTAT 30 and XSTAT 12 hemostatic devices in Europe.  Unlike traditional wound treatments that may take several minutes to be effective, XSTAT can stop bleeding in seconds to stabilize injuries until patients reach an emergency facility.

XSTAT devices work by injecting a group of small, rapidly-expanding sponges into a wound cavity using a syringe-like applicator. In a wound, the sponges rapidly expand and exert hemostatic pressure.  Since its receiving initial FDA-clearance in the United States in 2014, there have been numerous successful uses of XSTAT devices in civilian and military pre-hospital settings. 

Andrew Barofsky, President and CEO of RevMedx, Inc., stated, "CE Mark opens the opportunity for RevMedx to get our devices in the hands of emergency responders and surgeons in the European Union and around the world.   This certification clearly indicates that the XSTAT devices and our supporting quality system met the essential requirements for product safety, performance and usability, in compliance with rigorous requirements set by the EU's Medical Device Directive (MDD)."

For victims of violence or accidents, early control of severe bleeding may prevent shock and may be life-saving.  The United States Army Institute of Surgical Research reports that 30 to 40 percent of civilian deaths by traumatic injury are the result of hemorrhaging; of those deaths, 33 to 56 percent occur before the patient reaches an emergency care facility.

About RevMedx

Based in Wilsonville, Oregon, RevMedx is a privately held medical device company whose goal is to design, develop, and manufacture innovative medical products that save lives. Our product line includes XSTAT, XGAUZE, AIRWRAP, PARABELT, SHARKBITE Blast Injury Kits, and TX Series Ratcheting Tourniquets.  Additional information about RevMedx and our products can be found at www.revmedx.com.

Media Contact:

Will Fox

VP Sales & Marketing

Phone: (503) 218-2172

Email: will.fox@revmedx.com

Media Contact: Will Fox, RevMedx, Inc., 503-504-2642, will.fox@revmedx.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 

SOURCE RevMedx, Inc.

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store